Novel forward osmosis–membrane distillation system deployed for pharma ingredients production

This article was originally posted on chemengonline.com.

Japanese pharmaceutical contract development and manufacturing organization (CDMO) Peptistar has integrated Asahi Kasei Corp.’s novel forward osmosis–membrane distillation (FO–MD) system into its facility for trial production of active pharmaceutical ingredients (APIs). Asahi Kasei announced in 2018 the development of a system that dehydrates and concentrates liquids without the application of heat or pressure. This reduces […]

The post Novel forward osmosis–membrane distillation system deployed for pharma ingredients production appeared first on Chemical Engineering.

Novel forward osmosis–membrane distillation system deployed for pharma ingredients production

Related Conversations

Modeling technology for early-stage pharmaceutical water system design

Novel chlorine-resistant membranes set new standards for reverse osmosis

Syensqo and Memsift collaborating on membrane technologies for water applications

This RO element avoids biofouling in seawater desalination processes

This feed-interface system streamlines filter-press operations

Recent Conversations

Robots in substations: value only if they see what SCADA cannot

Selling the Boring Fix: Pricing Reliability Upgrades

Automating Substation Ops: Where It Helps and Where It Hurts

Leadership by 15 Minute Fixes

Closed-loop drumming: safer, cleaner, but watch the bottlenecks

Your Conversations

The Polaris Project at Yukon University Achieved the First Zero Carbon Building Design Certification for the Region

Lochner Rebrands as Egis, Advancing Growth Strategy Across the U.S.

MAIRE wins approximately €50 million in new awards in Asia, Europe and North America

Xanadu and Mitsubishi Chemical advance quantum computing collaboration for semiconductor manufacturing

SOEC green hydrogen test facility breaks ground at BASF’s Schwarzheide site